Cramer's 'Mad Money' Recap: The Balm in Gilead

Click here for an archive of Cramer's "Mad Money" recaps.

---

Ain't Nobody's Business

"If there's one thing you need to make money that most people never think about it's creativity," Jim Cramer told viewers of his "Mad Money" TV show Monday. "You have to be creative to beat the market."

So don't look for your ideas in the business section of the newspaper, he said, because once the company has made it to the business pages everyone knows about the stock.

That's why he said viewers should take a look at Gilead Sciences(GILD Quote), which was featured in an article he read in the New York Times Magazine this Sunday.

Cramer said that Gilead has an AIDS treatment called Viread that is being used as a preventative drug by some gay men to drastically reduce the chances of HIV infection.

This is an off-label use and there's no approval for it, Cramer warned, but he said that if it's ever approved it could make this company a fortune.

There are studies being conducted to determine just how effective Viread is as a preventative treatment, even though Gilead doesn't talk about it, he said.

But if it is proven effective, Cramer said it could totally change the way we fight AIDS.

Shares of Gilead were down today, provideing an opportunity to pick up the stock, he said.

Steel Is Real

Cramer's stock of the week is Oregon Steel Mills(OS Quote), despite the fact that steel has been an unsound business in which to invest.

But the past is the past, he said, and now it looks like there's a bull market in the sector because steel has become the second-hottest commodity in the world after oil.

The company is making the right product in an industry finally moving in the right direction, with a bidding war for Canadian steel company Dofasco going on in the background, he said.